How Remdesivir might inhibit the virus’s replication process?
Remdesivir is an antiviral drug that is used to treat severe cases of COVID-19, the disease caused by the SARS-CoV-2 virus. The drug works by inhibiting the virus’s replication process, which is essential for the virus to reproduce and spread.
SARS-CoV-2, like all viruses, relies on the host cell’s machinery to replicate its genome and produce new virus particles. The virus uses an enzyme called RNA-dependent RNA polymerase (RdRp) to replicate its RNA genome and synthesize new viral RNA molecules. Remdesivir targets the viral RdRp enzyme and prevents it from replicating the viral genome.
By inhibiting the replication of the viral genome, Remdesivir can reduce the amount of virus present in the body and potentially decrease the severity of the disease. However, it is important to note that Remdesivir is not a cure for COVID-19 and should be used in combination with other therapies to provide the best chance of a positive outcome.